Focus: Carbon Biosciences is a public biotechnology company headquartered in Waltham, MA, focused on gene therapy development. The company maintains a diversified portfolio spanning anesthetics, wound care, and oncology programs.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Carbon Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Legacy anesthetic generic with limited growth potential; revenue likely minimal in mature market.
Help build intelligence for Carbon Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Carbon Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Post-loss-of-exclusivity generic with minimal commercial significance.
Inhalation anesthetic generic in mature phase with limited differentiation.
Approved NDA indication for dermatology use; modest peak-phase revenue potential.
1 discontinued, 1 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub